Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXP5L7
|
||||
Drug Name |
(20R)-19,20,21,22-Tetrahydro-5-methyl-19-oxo-17H-18,20-ethano-6,10:12,1 6-dimetheno-16H-imidazo-[3,4-h][1,8,11,14]oxatriazacycloeicosine-9-carbonitrile
|
||||
Synonyms |
CHEMBL498042
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H23N5O2
|
||||
Canonical SMILES |
CC1c2ccc(C#N)c(Oc3cccc(CN4CC[C@@H](NCc5cncn15)C4=O)c3)c2
|
||||
InChI |
InChI=1S/C24H23N5O2/c1-16-18-5-6-19(11-25)23(10-18)31-21-4-2-3-17(9-21)14-28-8-7-22(24(28)30)27-13-20-12-26-15-29(16)20/h2-6,9-10,12,15-16,22,27H,7-8,13-14H2,1H3/t16?,22-/m1/s1
|
||||
InChIKey |
CIFGPLIJBYKXOG-VXNXSFHZSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.